Fortress Biotech now sits on a notably clean balance sheet, with roughly $256 million in cash against just $39 million of debt. Recent proceeds from the sale of its Menkes disease drug program leave the company well positioned to cover the approximately $16 million owed on deferred FBIOP preferred dividends. Those dividends have been deferred for nearly two years and could total as much as $4.69 per share if paid by mid-June 2026, which would meaningfully benefit large insider holders. On a sum-of-the-parts basis, FBIO's cash alone appears to exceed its equity market cap plus debt, preferred stock at par, and the deferred dividend obligation combined by roughly $24 million — suggesting the market is mispricing the balance sheet. Shares are also still about 35% below their January 2026 highs, adding to the case for an attractive entry point.
Aveanna Healthcare's Q1 2026 results beat both earnings and revenue expectations, with shares jumping 14% on the print — the ninth consecutive quarter of EPS beats and fourteenth straight quarter of revenue beats. There are real risks here, including elevated debt, negative free cash flow in the quarter, and some insider selling, but the valuation still looks reasonable with a forward P/E around 11.4 and a PEG ratio of 0.77. Improving profitability, continued expansion in home health and pediatric care, and raised full-year 2026 guidance support a bullish view. Shares are also still roughly 26% below their January 2026 highs.
SPCH was added purely as a way to get leveraged exposure to SpaceX, allowing the portfolio to participate in that growth story.
This lot of IRWD was closed for a modest gain of $5.50 (+3.1%). The exit was part of the broader push this week to build cash for new opportunities, and the position no longer fit the current GVR framework.
SATS was closed for a gain of $12.73 (+11.8%) after roughly three months. Same rationale as the other names trimmed this week — raising cash for better opportunities, with the position no longer aligning with the GVR framework.
The full 100-share IPSC position was closed for a loss of $20.00 (-8.2%) after roughly two months. The exit was driven by the same two factors as the rest of this week's closes: building cash for better opportunities, with the position no longer fitting the GVR framework.
This lot of ENOV was closed for a loss of $10.52 (-10.9%). As with the other exits this week, the move was about freeing up cash for new opportunities, with the position no longer aligning with the GVR framework.
GOOG was closed for a gain of $66.20 (+21.7%) after roughly four months. The exit follows the same logic applied across this week's closes — building cash for new opportunities, with the position no longer fitting the GVR framework.
This week's 100-share DSX closing sale, split across two lots, resulted in a loss of $10.38 (-4.3%). Consistent with the rest of this week's activity, the exit was about building cash for better opportunities, with the position no longer fitting the GVR framework.
BWXT was closed after a short nine-day hold for a gain of $48.82 (+8.7%). The exit reflects the two factors that applied across several positions trimmed this week: building cash for new and more attractive opportunities, and the position no longer screening well against the current GVR framework.
AXON was closed after roughly three weeks for a gain of $82.86 (+10.5%). As with several other names closed this week, the decision came down to freeing up cash for better-positioned opportunities, with the position no longer aligning with the GVR framework.
MU was originally framed as a memory-adjacent AI infrastructure play, riding the broader wave of demand for HBM and DRAM tied to AI data center buildout. After nearly tripling in value over roughly three and a half months, the stock had become significantly extended off that run. Rather than risk giving back those gains chasing further upside, the position was closed to lock in profits, with the plan to revisit the name on a pullback at a better entry point.
The original entry was predicated on a technical demand zone offering a favorable risk/reward setup for a bounce.
That demand zone failed to hold — price broke decisively below the level the entry was built on, leaving the chart structurally broken. Combined with thin margins and inconsistent earnings at the fundamental level, this no longer screened as a name worth defending. Rather than hold a falling knife on the hope of a reversion, the position was cut and the capital redeployed to better setups.
SM Energy was framed as a deep-value re-rating candidate within the E&P space, with the thesis centered on ongoing debt reduction and a high oil/gas pricing backdrop. Continued deleveraging was expected to strengthen the balance sheet meaningfully and unlock shareholder value over time, while the market appeared to be underappreciating the company's natural gas production and reserve base alongside expectations for crude oil prices to push even higher into the back half of the year. Strong share-buying momentum into early 2026 was read as a signal that a multi-year bull trend in the name could be underway. On valuation, the combined company was projected to trade at just ~3.9x 2027 earnings under conservative commodity price assumptions — well below the fossil fuel E&P group median of roughly 10x — making it one of the cheaper ways to gain exposure to the petroleum sector or a continuation of elevated crude prices.
The exit was driven by a shift in the macro backdrop rather than any deterioration in the company itself. With reports of progress toward a deal with Iran, the geopolitical premium embedded in crude prices looked increasingly likely to fade, and oil appeared to be topping out in the near term. That removes one of the key growth engines underpinning the thesis. Rather than wait for that view to play out and risk giving back the gain, the position was closed for a modest profit — an example of being proactive about taking wins off the table when the original catalyst structure changes, even before the chart confirms it.
Essentially the same thesis and exit logic as SM, applied to a more established, lower-beta name within the refining/integrated space: a play on elevated oil prices following the escalation of the Iran conflict. With signs of a potential de-escalation emerging and the geopolitical premium in crude likely to compress, the catalyst behind the trade was fading. The position was closed for a solid gain, consistent with the broader approach of taking profits when the underlying narrative shifts rather than waiting for price action to confirm it.
ZETA was identified as a mispriced AI marketing platform trading at a valuation still anchored to its legacy perception as an ad-tech company. The Seeking Alpha research at the time of entry made a compelling case that the market was missing a fundamental transformation underway: Zeta had launched Athena, a native AI layer built directly into the core marketing execution workflow — not bolted on top of it. Within one week of launch, Athena had generated 7x the agentic interactions and accounted for 60% of all platform AI activity, signaling rapid enterprise adoption. The Q1 2026 numbers backing this thesis were hard to ignore: revenue surged 50% year-over-year to $396 million, adjusted EBITDA climbed 42% to $66 million, and super-scaled customers grew 19% to 189 with ARPU jumping 21% to approximately $1.7 million. The organic growth rate, stripped of acquisitions and political revenue, was still running at 29%. At the time of entry, ZETA was trading below 17x forward earnings despite targeting over $2.3 billion in revenue and 25% EBITDA margins by 2028 — a clear valuation disconnect relative to the growth and profitability trajectory. Management's guidance toward positive GAAP EPS in 2026 was an additional catalyst, as it would open the stock to a broader institutional investor base that screens out GAAP-loss companies. The setup was a straightforward swing trade: a fundamentally improving business with a clear near-term re-rating catalyst, trading at a compressed multiple due to lingering short-seller sentiment and legacy misperception.
The position was exited on June 2, 2026 for a gain of $295.67 — approximately 30% in under two weeks. The exit was a disciplined take-profit decision: the position had reached a reasonable target return in a short timeframe and the broader market was showing signs of volatility heading into the NFP report on June 6. Locking in gains before a potentially market-moving macro event was the prudent move. In hindsight, given the significant Friday selloff that followed the jobs report, the timing proved to be even better than it looked at the moment of exit. The ZETA trade is a clean example of the swing trading discipline the GVR equity book is built on — identify a mispriced setup with a clear catalyst, size appropriately, and take profits when the thesis has played out rather than holding through unrelated macro risk.